Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Early Experiences With Nirsevimab: Perspectives From Newborn Hospitalists
2024
· Yale School of Medicine,
· Stanford University,
· Seattle Children's Hospital,
· The University of Chicago Medicine,
· Nationwide Children's Hospital,
· Yale University
This article discusses the implementation of newly developed nirsevimab into clinical practice. Approved in July 2023, it is costly and has supply issues. Hospitals struggle …
Exploring Parental Perspectives: Maternal RSV Vaccination Versus Infant RSV Monoclonal Antibody
This article looks at the comparison between two new ways to protect babies from respiratory syncytial virus (RSV): a maternal vaccine and an infant monoclonal …
Impact of Universal Immunization Program With Monoclonal Antibody Nirsevimab on Reducing the Burden of Serious Bronchiolitis That Need Pediatric Intensive Care
This study in Catalonia, Spain analyzed the effects of immunizing children with nirsevimab on bronchiolitis cases in pediatric intensive care units (PICU). The research compared …
High Uptake of Respiratory Syncitial Virus Prevention for Neonates in a Military Treatment Facility
2024
· Brooke Army Medical Center
This article discusses a study on the use of nirsevimab for infants and an RSV vaccine for pregnant women at a military hospital. It found …
Monoclonal Antibody Therapies in Respiratory Syncytial Virus Prophylaxis-An Umbrella Review
This article reviews the use of monoclonal antibodies to prevent respiratory syncytial virus (RSV) in infants. It describes how RSV causes many hospitalizations and deaths …
Real-World Effectiveness of Nirsevimab Against Respiratory Syncytial Virus: A Test-Negative Case-Control Study
2024
· Yale School of Medicine,
· Yale University
This article describes a study that evaluated the effectiveness of nirsevimab in preventing RSV infections in infants. It included 3,090 infants and found that nirsevimab …
Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children: Rationale and Progress to Date
This article discusses recent research around respiratory syncytial virus (RSV), which is a common cause of lower respiratory tract infection in children, leading to long-term …
Nirsevimab Administration During the Birth Hospitalization
This brief report describes a study focused on the birth hospital nirsevimab administration rate and compared it to the hepatitis B vaccine rate in the …
Factors Associated With Nirsevimab Uptake in Healthy Newborns
2024
· Yale School of Medicine,
· Yale University
This research brief discusses a study that looks at factors affecting the use of nirsevimab, a new antibody for RSV, in newborns. It explains how …
Nirsevimab Effectiveness Against Severe RSV Infection in the Primary Care Setting
This study in Spain evaluated nirsevimab's efficacy in preventing respiratory syncytial virus (RSV) infections in infants under ten months. The immunization campaign targeted all infants …